Results 271 to 280 of about 161,983 (298)
Some of the next articles are maybe not open access.
European Journal of Cancer
Immune checkpoint blockers (ICBs) can induce immune-related adverse events (irAEs) whose management is based on expert opinion and may require the prescription of steroids and/or immunosuppressants (ISs). Recent data suggest that these treatments can reduce the effectiveness of ICBs.To investigate the relationship between the use of steroids and/or ISs
Pierre-Louis, Cariou +12 more
openaire +2 more sources
Immune checkpoint blockers (ICBs) can induce immune-related adverse events (irAEs) whose management is based on expert opinion and may require the prescription of steroids and/or immunosuppressants (ISs). Recent data suggest that these treatments can reduce the effectiveness of ICBs.To investigate the relationship between the use of steroids and/or ISs
Pierre-Louis, Cariou +12 more
openaire +2 more sources
Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid
European Journal of Cancer, 2021Connie R, Shi +5 more
openaire +2 more sources
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Cytotoxic T Cells Are Replaced by Novel Clones After Immune Checkpoint Blocker Therapy
Journal of Cutaneous Medicine and Surgery, 2020Pingxing Xie +2 more
openaire +2 more sources
Therapeutic Development of Immune Checkpoint Inhibitors.
Advances in Experimental Medicine and Biology, 2020Jilin Wang, T. Yang, Jie Xu
semanticscholar +1 more source
Abstract #1023: Endocrinopathies Related to Immune Checkpoint Blockers
Endocrine Practice, 2017openaire +1 more source